Stock Information

Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc logo
Ticker Symbol: KROS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $365.90 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.70
Revenue (TTM): $0.76 M
Dividend Yield: N/A
ROE: -21.4%

Latest News

Key Financials

Financial data not available